Beranda › Infeksi Adenoviridae › Ohio
Uji klinis Infeksi Adenoviridae di Ohio
7 studi untuk Infeksi Adenoviridae mencari peserta di lokasi di Ohio.
Kota di Ohio
Teks studi resmi (Bahasa Inggris)
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
- Nationwide Children's Hospital, Columbus
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 1 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT03665675Donor-Derived Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
Menerima pesertaFase 1/2
4 Weeks · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
Menerima pesertaFase 2
2 Days · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02532452A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- University of Cincinnati Cancer Center, Cincinnati
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07544589A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
Menerima pesertaFase 3
2 Months · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07387367Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
- Nationwide Children's Hosptial, Columbus
Menerima pesertaFase 2
1 Month – 79 Years · Semua jenis kelamin · Diperbarui 8 Agu 2025 · NCT03266627Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections
- Nationwide Children's Hospital, Columbus
Menerima pesertaFase 1/2
Hingga usia 60 · Semua jenis kelamin · Diperbarui 13 Mei 2025 · NCT04722029Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.